Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Administration of Apis cerana cerana melittin gene-encapsulated pectin for breast cancer therapy: an investigation of a new anti-cancer agent

Fig. 5

A IC50 values in the study groups after 24-h treatment of the MCF-7, SKBR3, and MCF-10A cell lines with Melittin, blank pectin, pDNA/Melittin, and pDNA/Melittin/pectin were statistically significant (P < 0.001***). The impact of dilute solutions of Melittin, blank pectin, pDNA/Melittin, and pDNA/Melittin/pectin on cell viability were assessed in MCF-7 (B), SKBR3 (C), and MCF-10A (D) cell lines. Data is presented as mean ± SEM

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us